Cargando…

No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe

BACKGROUND: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients sufferin...

Descripción completa

Detalles Bibliográficos
Autores principales: Stieler, Kristin, Schindler, Sarah, Schlomm, Thorsten, Hohn, Oliver, Bannert, Norbert, Simon, Ronald, Minner, Sarah, Schindler, Michael, Fischer, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192048/
https://www.ncbi.nlm.nih.gov/pubmed/22022417
http://dx.doi.org/10.1371/journal.pone.0025592
_version_ 1782213708093587456
author Stieler, Kristin
Schindler, Sarah
Schlomm, Thorsten
Hohn, Oliver
Bannert, Norbert
Simon, Ronald
Minner, Sarah
Schindler, Michael
Fischer, Nicole
author_facet Stieler, Kristin
Schindler, Sarah
Schlomm, Thorsten
Hohn, Oliver
Bannert, Norbert
Simon, Ronald
Minner, Sarah
Schindler, Michael
Fischer, Nicole
author_sort Stieler, Kristin
collection PubMed
description BACKGROUND: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients suffering from chronic fatigue syndrome (CFS), as well as from a significant number of healthy controls prompted us to deepen our studies about detection of XMRV infection applying different detection methods (PCR, cocultivation and immunohistochemistry [IHC]). METHODOLOGY/PRINCIPAL FINDINGS: Peripheral blood mononuclear cells (PBMCs) from 92 PCA and 7 healthy controls were isolated, PHA activated and cocultivated with LNCaP cells for up to 8 weeks. Supernatant of these cells was applied to a reporter cell line, DERSE-iGFP. Furthermore, the PBMCs and cocultivated LNCaP cells were tested for the presence of XMRV by PCR as well as Western Blot analysis. While all PCR amplifications and Western Blot analyses were negative for signs of XMRV infection, DERSE-iGFP cells displayed isolated GFP positive cells in three cases. In all three cases XMRV presence could not be confirmed by PCR technology. In addition, we performed XMRV specific IHC on PCA tissue sections. Whole tissue sections (n = 20), as well as tissue microarrays (TMA) including 50 benign prostate hyperplasia (BPH), 50 low grade and 50 high grade PCA sections and TMAs including breast cancer, colon cancer and normal tissues were stained with two XMRV specific antisera. XMRV protein expression was not detected in any cancer sections included. One BPH tissue displayed XMRV specific protein expression in random isolated basal cells. CONCLUSION: We were unable to conclusively detect XMRV in the blood from PCA patients or from healthy controls and there is no conclusive evidence of XMRV protein expression in PCA, breast cancer and colon cancer tissue sections tested by IHC staining.
format Online
Article
Text
id pubmed-3192048
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31920482011-10-21 No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe Stieler, Kristin Schindler, Sarah Schlomm, Thorsten Hohn, Oliver Bannert, Norbert Simon, Ronald Minner, Sarah Schindler, Michael Fischer, Nicole PLoS One Research Article BACKGROUND: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients suffering from chronic fatigue syndrome (CFS), as well as from a significant number of healthy controls prompted us to deepen our studies about detection of XMRV infection applying different detection methods (PCR, cocultivation and immunohistochemistry [IHC]). METHODOLOGY/PRINCIPAL FINDINGS: Peripheral blood mononuclear cells (PBMCs) from 92 PCA and 7 healthy controls were isolated, PHA activated and cocultivated with LNCaP cells for up to 8 weeks. Supernatant of these cells was applied to a reporter cell line, DERSE-iGFP. Furthermore, the PBMCs and cocultivated LNCaP cells were tested for the presence of XMRV by PCR as well as Western Blot analysis. While all PCR amplifications and Western Blot analyses were negative for signs of XMRV infection, DERSE-iGFP cells displayed isolated GFP positive cells in three cases. In all three cases XMRV presence could not be confirmed by PCR technology. In addition, we performed XMRV specific IHC on PCA tissue sections. Whole tissue sections (n = 20), as well as tissue microarrays (TMA) including 50 benign prostate hyperplasia (BPH), 50 low grade and 50 high grade PCA sections and TMAs including breast cancer, colon cancer and normal tissues were stained with two XMRV specific antisera. XMRV protein expression was not detected in any cancer sections included. One BPH tissue displayed XMRV specific protein expression in random isolated basal cells. CONCLUSION: We were unable to conclusively detect XMRV in the blood from PCA patients or from healthy controls and there is no conclusive evidence of XMRV protein expression in PCA, breast cancer and colon cancer tissue sections tested by IHC staining. Public Library of Science 2011-10-12 /pmc/articles/PMC3192048/ /pubmed/22022417 http://dx.doi.org/10.1371/journal.pone.0025592 Text en Stieler et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Stieler, Kristin
Schindler, Sarah
Schlomm, Thorsten
Hohn, Oliver
Bannert, Norbert
Simon, Ronald
Minner, Sarah
Schindler, Michael
Fischer, Nicole
No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe
title No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe
title_full No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe
title_fullStr No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe
title_full_unstemmed No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe
title_short No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe
title_sort no detection of xmrv in blood samples and tissue sections from prostate cancer patients in northern europe
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192048/
https://www.ncbi.nlm.nih.gov/pubmed/22022417
http://dx.doi.org/10.1371/journal.pone.0025592
work_keys_str_mv AT stielerkristin nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT schindlersarah nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT schlommthorsten nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT hohnoliver nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT bannertnorbert nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT simonronald nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT minnersarah nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT schindlermichael nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope
AT fischernicole nodetectionofxmrvinbloodsamplesandtissuesectionsfromprostatecancerpatientsinnortherneurope